Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 15.4B | 15.0B | 11.9B | 13.0B |
Cost of revenue | 12.2B | 9.2B | 8.5B | 10.8B |
Gross profit | 3.2B | 5.8B | 3.4B | 2.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 915.5M | 33.9M | 1.1B | 795.9M |
Operating income | 905.4M | 3.5B | 801.6M | 58.9M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 336.7M | 295.0M | 69.4M | 200.3M |
Other income expense | — | — | — | — |
Pretax income | 730.8M | 3.1B | 890.2M | 591.5M |
Tax provision | 215.1M | 825.8M | 185.5M | -80.2M |
Net income | 515.7M | 2.3B | 704.7M | 671.8M |
Basic EPS | 2.6 | — | 3.5 | 3.3 |
Diluted EPS | 2.5 | — | 3.5 | 3.3 |
Basic average shares | 202.2M | — | 201.9M | 201.7M |
Diluted average shares | 203.8M | — | 202.5M | 202.9M |
EBITDA | 1.5B | 3.2B | 1.4B | 1.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |